COVID-19: What You Need to Know

Summary

At Cedars-Sinai, our top priority is the health and safety of our patients, visitors and staff. We always use the best safety practices to protect the health of everyone who comes to our hospitals and clinics.

Our care teams are experts in treating new and emerging diseases, utilizing infection prevention protocols from the Centers for Disease Control and Prevention (CDC). We continue to coordinate closely with local, state and federal health agencies.

If you are a Cedars-Sinai patient or visitor, learn more about any updates related to COVID-19 that might affect you.

Click here for links to media coverage of Cedars-Sinai's COVID-19 response. 

August
24,
2022
| 13:01 PM America/Los_Angeles
Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk—but that severe COVID-19 infection does. Physician-scientists hope this
August
18,
2022
| 06:01 AM America/Los_Angeles
For the past two-plus years, the COVID-19 pandemic has disrupted children’s education and frustrated parents. Today, with the back-to-school season in full swing, Suzanne Silverstein, MA, ART, founding director of Cedars-Sinai Share & Care, and Rose
August
17,
2022
| 08:00 AM America/Los_Angeles
The majority of people who were likely infected with the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, didn’t know they had the virus, according to a new study from Cedars-Sinai investigators. The findings are published in JAMA
July
21,
2022
| 06:07 AM America/Los_Angeles
Hypertension more than doubles the risk of hospitalization related to Omicron infection, even in people who are fully vaccinated and boosted, according to a new study led by investigators in the Smidt Heart Institute at Cedars-Sinai. The findings
July
13,
2022
| 06:15 AM America/Los_Angeles
A new report on lung transplantation success rates confirms that Cedars-Sinai patients experienced one-year survival outcomes of 91.49%, an achievement above the national average of 89.46%.  The data—compiled by the Scientific Registry of Transplant
July
07,
2022
| 09:00 AM America/Los_Angeles
Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the
July
07,
2022
| 07:00 AM America/Los_Angeles
People infected with the virus that causes COVID-19 who later receive two doses of the Pfizer-BioNTech vaccine have elevated antibody levels that last at least 10 months, according to a new study by Cedars-Sinai investigators. The results are
July
05,
2022
| 07:01 AM America/Los_Angeles
When it comes to COVID-19 immunity, antibodies do not tell the whole story, according to Cedars-Sinai professor of Medicine Stanley C. Jordan, MD.Jordan should know. As director of the Comprehensive Transplant Center’s Human Leukocyte Antigen and
June
29,
2022
| 06:00 AM America/Los_Angeles
As families and friends plan for fireworks, picnics and fun this July Fourth, they should also prepare for COVID-19 safety.“We’re currently dealing with a surge of COVID in Los Angeles County, the scope of which has been underestimated given the
June
22,
2022
| 07:01 AM America/Los_Angeles
For many families with young children, the moment they have been waiting for has finally arrived: The U.S. Food and  Drug Administration (FDA) has authorized emergency use of two COVID-19 vaccines made by Moderna and Pfizer-BioNTech for children 6
May
23,
2022
| 07:00 AM America/Los_Angeles
Getting the COVID-19 vaccination strengthened one type of immune response to the SARS-CoV-2 virus in inflammatory bowel disease (IBD) patients even though they were taking immunosuppressant medication, according to investigators at Cedars-Sinai.The